![](/img/cover-not-exists.png)
AKT mediates the pro-survival effects of KIT in ovarian cancer cells and is a determinant of sensitivity to imatinib mesylate
Tanya J. Shaw, Barbara C. VanderhydenVolume:
105
Year:
2007
Language:
english
Pages:
10
DOI:
10.1016/j.ygyno.2006.10.052
File:
PDF, 782 KB
english, 2007